Du benytter en nettleser vi ikke støtter. Se informasjon om nettlesere

. Referanser

Aldape, K., Simmons, M. L., Davis, R. L., Miike, R., Wiencke, J., Barger, G., . . . Wrensch, M. (2000). Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer., 88(10), 2342-2349.

Baumert, B. G., Hegi, M. E., van den Bent, M. J., von Deimling, A., Gorlia, T., Hoang-Xuan, K., . . . Stupp, R. (2016). Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11), 1521-1532. https://doi.org/10.1016/s1470-2045(16)30313-8

Blonski, M., Pallud, J., Goze, C., Mandonnet, E., Rigau, V., Bauchet, L., . . . Taillandier, L. (2013). Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients. J Neurooncol., 113(2), 267-275. doi: 210.1007/s11060-11013-11106-11066.

Brat, D. J., Aldape, K., Colman, H., Holland, E. C., Louis, D. N., Jenkins, R. B., . . . Weller, M. (2018). cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". Acta Neuropathologica, 136(5), 805-810. https://doi.org/10.1007/s00401-018-1913-0

Brat, D. J., Verhaak, R. G., Aldape, K. D., Yung, W. K., Salama, S. R., Cooper, L. A., . . . Zhang, J. (2015). Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. New England Journal of Medicine, 372(26), 2481-2498. https://doi.org/10.1056/NEJMoa1402121

Buckner, J. C., Shaw, E. G., Pugh, S. L., Chakravarti, A., Gilbert, M. R., Barger, G. R., . . . Curran, W. J., Jr. (2016). Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. New England Journal of Medicine, 374(14), 1344-1355. https://doi.org/10.1056/NEJMoa1500925

Capelle, L., Fontaine, D., Mandonnet, E., Taillandier, L., Golmard, J. L., Bauchet, L., . . . Duffau, H. (2013). Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article. J Neurosurg., 118(6), 1157-1168. doi: 1110.3171/2013.1151.JNS1121.

Chaichana, K. L., McGirt, M. J., Laterra, J., Olivi, A., & Quinones-Hinojosa, A. (2010). Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg., 112(1), 10-17. doi: 10.3171/2008.3110.JNS08608.

Chang, E. F., Potts, M. B., Keles, G. E., Lamborn, K. R., Chang, S. M., Barbaro, N. M., & Berger, M. S. (2008). Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg., 108(2), 227-235. doi: 210.3171/JNS/2008/3108/3172/0227.

Claus, E. B., Horlacher, A., Hsu, L., Schwartz, R. B., Dello-Iacono, D., Talos, F., . . . Black, P. M. (2005). Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer., 103(6), 1227-1233.

Coburger, J., Merkel, A., Scherer, M., Schwartz, F., Gessler, F., Roder, C., . . . Wirtz, C. R. (2016). Low-grade Glioma Surgery in Intraoperative Magnetic Resonance Imaging: Results of a Multicenter Retrospective Assessment of the German Study Group for Intraoperative Magnetic Resonance Imaging. Neurosurgery, 78(6), 775-786. https://doi.org/10.1227/neu.0000000000001081

Combs, S. E., Thilmann, C., Edler, L., Debus, J., & Schulz-Ertner, D. (2005). Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. Journal of Clinical Oncology, 23(34), 8863-8869. https://doi.org/10.1200/jco.2005.03.4157

Douw, L., Klein, M., Fagel, S. S., van den Heuvel, J., Taphoorn, M. J., Aaronson, N. K., . . . Heimans, J. J. (2009). Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurology, 8(9), 810-818. doi: 810.1016/S1474-4422(1009)70204-70202.

Dropcho, E. J., & Soong, S. J. (1996). The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a case-control study. Neurology., 47(3), 684-690.

Eckel-Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., . . . Jenkins, R. B. (2015). Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. New England Journal of Medicine, 372(26), 2499-2508. https://doi.org/10.1056/NEJMoa1407279

Forskrift om prioritering av helsetjenester, rett til nødvendig helsehjelp fra spesialisthelsetjenesten, rett til behandling i utlandet og om klagenemnd (prioriteringsforskriften). FOR-2000-12-01-1208. Last update in FOR-2020-02-04-119 fra 01.03.2020. Retrieved from https://lovdata.no/dokument/SF/forskrift/2000-12-01-1208

Gehring, K., Sitskoorn, M. M., Gundy, C. M., Sikkes, S. A., Klein, M., Postma, T. J., . . . Aaronson, N. K. (2009). Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol., 27(22), 3712-3722. doi: 3710.1200/JCO.2008.3720.5765.

Gilbert, M. R., Wang, M., Aldape, K. D., Stupp, R., Hegi, M. E., Jaeckle, K. A., . . . Mehta, M. P. (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32), 4085-4091. https://doi.org/10.1200/jco.2013.49.6968

Habets, E. J., Taphoorn, M. J., Nederend, S., Klein, M., Delgadillo, D., Hoang-Xuan, K., . . . Reijneveld, J. C. (2014). Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors. Journal of Neuro-Oncology, 116(1), 161-168. https://doi.org/10.1007/s11060-013-1278-0

Ius, T., Isola, M., Budai, R., Pauletto, G., Tomasino, B., Fadiga, L., & Skrap, M. (2012). Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article. J Neurosurg., 117(6), 1039-1052. doi: 1010.3171/2012.1038.JNS12393.

Jackson, R. J., Fuller, G. N., Abi-Said, D., Lang, F. F., Gokaslan, Z. L., Shi, W. M., . . . Sawaya, R. (2001). Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-Oncology, 3(3), 193-200.

Jakola, A. S., Myrmel, K. S., Kloster, R., Torp, S. H., Lindal, S., Unsgard, G., & Solheim, O. (2012a). Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA, 308(18), 1881-1888. https://doi.org/10.1001/jama.2012.12807

Jakola, A. S., Myrmel, K. S., Kloster, R., Torp, S. H., Lindal, S., Unsgard, G., & Solheim, O. (2012b). Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas. Jama, 25, 1-8.

Jakola, A. S., Unsgard, G., Myrmel, K. S., Kloster, R., Torp, S. H., Lindal, S., & Solheim, O. (2012). Low grade gliomas in eloquent locations - implications for surgical strategy, survival and long term quality of life. PLoS One., 7(12), e51450. doi: 51410.51371/journal.pone.0051450.

Jakola, A. S., Unsgard, G., Myrmel, K. S., Kloster, R., Torp, S. H., Losvik, O. K., . . . Solheim, O. (2013). Surgical strategy in grade II astrocytoma: a population-based analysis of survival and morbidity with a strategy of early resection as compared to watchful waiting. Acta Neurochirurgica, 155(12), 2227-2235. https://doi.org/10.1007/s00701-013-1869-8

Jakola, A. S., Unsgard, G., Myrmel, K. S., Kloster, R., Torp, S. H., Sagberg, L. M., . . . Solheim, O. (2014). Surgical strategies in low-grade gliomas and implications for long-term quality of life. Journal of Clinical Neuroscience, 2(14), 00055-00051.

Johannesen, T. B., Langmark, F., & Lote, K. (2003). Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg., 99(5), 854-862.

Johnson, B. E., Mazor, T., Hong, C., Barnes, M., Aihara, K., McLean, C. Y., . . . Costello, J. F. (2014). Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science, 343(6167), 189-193. https://doi.org/10.1126/science.1239947

Karim, A. B., Maat, B., Hatlevoll, R., Menten, J., Rutten, E. H., Thomas, D. G., . . . van Glabbeke, M. (1996). A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys., 36(3), 549-556.

Kesari, S., Schiff, D., Drappatz, J., LaFrankie, D., Doherty, L., Macklin, E. A., . . . Wen, P. Y. (2009). Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res., 15(1), 330-337. doi: 310.1158/1078-0432.CCR-1108-0888.

Kiebert, G. M., Curran, D., Aaronson, N. K., Bolla, M., Menten, J., Rutten, E. H., . . . Karim, A. B. (1998). Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer., 34(12), 1902-1909.

Landberg, T., Chavaudra, J., Dobbs, J., Gerard, J. P., Hanks, G., Horiot, J. C., . . . Svensson, H. (1999). Report 62: prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU report 50). Journal of the International Commission on Radiation Units and Measurements, os32(1).

Landberg, T., Chavaudra, J., Dobbs, J., Hanks, G., Johansson, K.-A., Möller, T., & Purdy, J. (1993). Report 50: Prescribing, Recording, and Reporting Photon Beam Therapy. Journal of the ICRU, os26(1).

Lasocki, A., Tsui, A., Tacey, M. A., Drummond, K. J., Field, K. M., & Gaillard, F. (2015). MRI grading versus histology: predicting survival of World Health Organization grade II-IV astrocytomas. AJNR: American Journal of Neuroradiology, 36(1), 77-83. https://doi.org/10.3174/ajnr.A4077

Leighton, C., Fisher, B., Macdonald, D., Stitt, L., Bauman, G., & Cairncross, J. (2007). The dose-volume interaction in adult supratentorial low-grade glioma: higher radiation dose is beneficial among patients with partial resection. J Neurooncol., 82(2), 165-170.

Leve med kreft: nasjonal kreftstrategi (2018–2022). (2018). Oslo: Helse- og omsorgsdepartementet. Retrieved from https://www.regjeringen.no/no/dokumenter/leve-med-kreft/id2598282/

Levernes, S. (2012). Volum og doser i ekstern stråleterapi: definisjoner og anbefalinger (StrålevernRapport 2012:9). Østerås: Statens strålevern. Retrieved from https://dsa.no/medisinsk-stralebruk/kvist/_/attachment/download/bee8860b-36d1-42e7-8d64-f5ad4fcef2e8:8ebb86decddc2818ec31e4999d26cdf7aec14ac2/StralevernRapport_09-2012.pdf

Levernes, S. (2019). Faglige anbefalinger for nomenklatur for volumer i stråleterapi (Teknisk dokument 14). Østerås: Direktoratet for strålevern og atomsikkerhet. Retrieved from https://dsa.no/publikasjoner/_/attachment/download/9d2a42a5-241e-4299-86cf-6b02a0abf3b9:2400dff7cb71f4bff583473d690fcb79650dd59e/TekniskDokument14_rev2020.pdf

Louis, D. N., Ohgaki, H., Wiestler, O. W., & Cavenee, W. K. (Eds.). (2016). WHO classification of tumours of the central nervous system (4. rev. ed.). (Tumours of the Central nervous system). Lyon: IARC Press.

Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., . . . Ellison, D. W. (2016). The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica, 131(6), 803-820. https://doi.org/10.1007/s00401-016-1545-1

Lov om kommunale helse- og omsorgstjenester m.m. (helse- og omsorgstjenesteloven). LOV-2011-06-24-30. Last update in LOV-2019-06-21-45 fra 01.01.2020. Retrieved from https://lovdata.no/dokument/NL/lov/2011-06-24-30

Lov om pasient- og brukerrettigheter (pasient- og brukerrettighetsloven). LOV-1999-07-02-63. Last update in LOV-2019-12-20-104 fra 01.03.2020. Retrieved from https://lovdata.no/dokument/NL/lov/1999-07-02-63

Mandonnet, E., Delattre, J.-Y., Tanguy, M.-L., Swanson, K. R., Carpentier, A. F., Duffau, H., . . . Capelle, L. (2003). Continuous growth of mean tumor diameter in a subset of grade II gliomas. Annals of Neurology, 53(4), 524-528. https://doi.org/10.1002/ana.10528

Marienhagen, K., Djupvik, L. H., & Danielsen, T. (2020). Faglige anbefalinger for inntegning av risikoorganer i CNS (Teknisk dokument 16). Østerås: Direktoratet for strålevern og atomsikkerhet. Retrieved from https://dsa.no/publikasjoner/_/attachment/download/401a60b3-b7db-4c4a-b741-da0a70c43b20:f0c3325a0ec4a43b2335cf17df266e4e7c34408c/Teknisk%20dokument16_rev.pdf

McGirt, M. J., Chaichana, K. L., Attenello, F. J., Weingart, J. D., Than, K., Burger, P. C., . . . Quinones-Hinojosa, A. (2008). Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery., 63(4), 700-707; author reply 707-708. doi: 710.1227/1201.NEU.0000325729.0000341085.0000325773.

Nasjonal helseplan (2007–2010). (2006). (Særtrykk av St.prp. nr. 1 (2006–2007) kapittel 6). Oslo: Helse- og omsorgsdepartementet. Retrieved from https://www.regjeringen.no/globalassets/upload/hod/sykehus/nasjonal_helseplan_sartrykk.pdf

Nasjonal strategi for kreftområdet 2006-2009. (2006). Oslo: Helse- og omsorgsdepartementet. Retrieved from https://www.regjeringen.no/no/dokumenter/nasjonal-strategi-for-kreftomradet/id446845/

Pace, A., Vidiri, A., Galie, E., Carosi, M., Telera, S., Cianciulli, A. M., . . . Carapella, C. M. (2003). Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol., 14(12), 1722-1726.

Pallud, J., Blonski, M., Mandonnet, E., Audureau, E., Fontaine, D., Sanai, N., . . . Capelle, L. (2013). Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas. Neuro-Oncology, 15(5), 595-606. doi: 510.1093/neuonc/nos1331.

Pallud, J., Capelle, L., Taillandier, L., Fontaine, D., Mandonnet, E., Guillevin, R., . . . Duffau, H. (2009). Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro-Oncology, 11(2), 176-182. https://doi.org/10.1215/15228517-2008-066

Pignatti, F., van den Bent, M., Curran, D., Debruyne, C., Sylvester, R., Therasse, P., . . . Karim, A. B. (2002). Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol., 20(8), 2076-2084.

Quinn, J. A., Reardon, D. A., Friedman, A. H., Rich, J. N., Sampson, J. H., Provenzale, J. M., . . . Friedman, H. S. (2003). Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol., 21(4), 646-651.

Rees, J., Watt, H., Jager, H. R., Benton, C., Tozer, D., Tofts, P., & Waldman, A. (2009). Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol., 72(1), 54-64. doi: 10.1016/j.ejrad.2008.1006.1013.

Report 78: Prescribing, Recording, and Reporting Proton-Beam Therapy. (2007). Journal of the ICRU, 7(7).

Report 83: Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT). (2010). Journal of the ICRU, 10(1).

Sabha, N., Knobbe, C. B., Maganti, M., Al Omar, S., Bernstein, M., Cairns, R., . . . Croul, S. (2014). Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas. Neuro-Oncology, 26, 26.

Sammen - mot kreft: nasjonal kreftstrategi 2013-2017. (2013). Oslo: Helse- og omsorgsdepartementet. Retrieved from https://www.regjeringen.no/no/dokumenter/sammen---mot-kreft/id728818/

Scheie, D., Meling, T. R., Cvancarova, M., Skullerud, K., Mork, S., Lote, K., . . . Beiske, K. (2011). Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases. Neuro-Oncology, 13(11), 1225-1233. https://doi.org/10.1093/neuonc/nor114

Shaw, E., Arusell, R., Scheithauer, B., O'Fallon, J., O'Neill, B., Dinapoli, R., . . . Abrams, R. (2002). Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol., 20(9), 2267-2276.

Shaw, E. G., Berkey, B., Coons, S. W., Bullard, D., Brachman, D., Buckner, J. C., . . . Mehta, M. (2008). Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg., 109(5), 835-841. doi: 810.3171/JNS/2008/3109/3111/0835.

Shaw, E. G., Wang, M., Coons, S. W., Brachman, D. G., Buckner, J. C., Stelzer, K. J., . . . Mehta, M. P. (2012). Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. Journal of Clinical Oncology, 30(25), 3065-3070. https://doi.org/10.1200/jco.2011.35.8598

Smith, J. S., Chang, E. F., Lamborn, K. R., Chang, S. M., Prados, M. D., Cha, S., . . . Berger, M. S. (2008). Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol., 26(8), 1338-1345. doi: 1310.1200/JCO.2007.1313.9337.

Smoll, N. R., Gautschi, O. P., Schatlo, B., Schaller, K., & Weber, D. C. (2012). Relative survival of patients with supratentorial low-grade gliomas. Neuro-Oncology, 14(8), 1062-1069. doi: 1010.1093/neuonc/nos1144. Epub 2012 Jul 1066.

Soffietti, R., Baumert, B. G., Bello, L., von Deimling, A., Duffau, H., Frenay, M., . . . Wick, W. (2010). Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol., 17(9), 1124-1133. doi: 1110.1111/j.1468-1331.2010.03151.x.

van den Bent, M. J., Afra, D., de Witte, O., Ben Hassel, M., Schraub, S., Hoang-Xuan, K., . . . Karim, A. B. (2005). Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet., 366(9490), 985-990.

Wen, P. Y., Yung, W. K., Lamborn, K. R., Norden, A. D., Cloughesy, T. F., Abrey, L. E., . . . Prados, M. D. (2009). Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro-Oncology, 11(6), 853-860. https://doi.org/10.1215/15228517-2009-010

Wijnenga, M. M. J., French, P. J., Dubbink, H. J., Dinjens, W. N. M., Atmodimedjo, P. N., Kros, J. M., . . . van den Bent, M. J. (2018). The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Neuro-Oncology, 20(1), 103-112. doi: 110.1093/neuonc/nox1176.

Woodworth, G., McGirt, M. J., Samdani, A., Garonzik, I., Olivi, A., & Weingart, J. D. (2005). Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res., 27(4), 358-362.

Zhang, Z. Y., Chan, A. K., Ng, H. K., Ding, X. J., Li, Y. X., Shi, Z. F., . . . Zhou, L. F. (2014). Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis. International Journal of Clinical and Experimental Pathology, 7(12), 8627-8636.

Aaronson, N. K., Taphoorn, M. J., Heimans, J. J., Postma, T. J., Gundy, C. M., Beute, G. N., . . . Klein, M. (2011). Compromised health-related quality of life in patients with low-grade glioma. J Clin Oncol., 29(33), 4430-4435. doi: 4410.1200/JCO.2011.4435.5750.

Sist faglig oppdatert: 31. desember 2020